Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.
|
Clin Gastroenterol Hepatol
|
2007
|
6.19
|
2
|
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.
|
Genome Biol
|
2012
|
5.66
|
3
|
Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.
|
J Pediatr Gastroenterol Nutr
|
2013
|
2.65
|
4
|
A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.
|
Am J Gastroenterol
|
2012
|
2.63
|
5
|
Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience.
|
J Pediatr Gastroenterol Nutr
|
2005
|
1.98
|
6
|
Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease.
|
J Pediatr Gastroenterol Nutr
|
2013
|
1.82
|
7
|
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
|
Clin Infect Dis
|
2014
|
1.81
|
8
|
Management of ingested magnets in children.
|
J Pediatr Gastroenterol Nutr
|
2012
|
1.78
|
9
|
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
|
J Pediatr Gastroenterol Nutr
|
2007
|
1.74
|
10
|
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
|
Clin Infect Dis
|
2013
|
1.69
|
11
|
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.
|
PLoS One
|
2012
|
1.66
|
12
|
Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study.
|
J Pediatr Gastroenterol Nutr
|
2004
|
1.60
|
13
|
Depression subtypes in pediatric inflammatory bowel disease.
|
J Pediatr Gastroenterol Nutr
|
2014
|
1.57
|
14
|
Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
|
Am J Gastroenterol
|
2004
|
1.53
|
15
|
Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation.
|
Inflamm Bowel Dis
|
2006
|
1.43
|
16
|
Predictors of depression in youth with Crohn disease.
|
J Pediatr Gastroenterol Nutr
|
2014
|
1.42
|
17
|
An i2b2-based, generalizable, open source, self-scaling chronic disease registry.
|
J Am Med Inform Assoc
|
2012
|
1.39
|
18
|
Efficacy of probiotic use in acute diarrhea in children: a meta-analysis.
|
Dig Dis Sci
|
2002
|
1.38
|
19
|
Immune response to influenza vaccine in children with inflammatory bowel disease.
|
Am J Gastroenterol
|
2009
|
1.37
|
20
|
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.
|
Clin Gastroenterol Hepatol
|
2006
|
1.33
|
21
|
The natural history of corticosteroid therapy for ulcerative colitis in children.
|
Clin Gastroenterol Hepatol
|
2006
|
1.33
|
22
|
Risk of early surgery for Crohn's disease: implications for early treatment strategies.
|
Am J Gastroenterol
|
2003
|
1.29
|
23
|
Variation in care in pediatric Crohn disease.
|
J Pediatr Gastroenterol Nutr
|
2009
|
1.26
|
24
|
Complementary medicine use in children and young adults with inflammatory bowel disease.
|
Am J Gastroenterol
|
2002
|
1.26
|
25
|
Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.22
|
26
|
Appraisal of the pediatric ulcerative colitis activity index (PUCAI).
|
Inflamm Bowel Dis
|
2009
|
1.18
|
27
|
Intercenter variation in initial management of children with Crohn's disease.
|
Inflamm Bowel Dis
|
2007
|
1.17
|
28
|
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease.
|
Inflamm Bowel Dis
|
2008
|
1.17
|
29
|
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.
|
Am J Gastroenterol
|
2011
|
1.16
|
30
|
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms.
|
J Pediatr Gastroenterol Nutr
|
2009
|
1.15
|
31
|
Outcome following infliximab therapy in children with ulcerative colitis.
|
Am J Gastroenterol
|
2010
|
1.14
|
32
|
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease.
|
Inflamm Bowel Dis
|
2009
|
1.13
|
33
|
A review of activity indices and end points for clinical trials in children with Crohn's disease.
|
Inflamm Bowel Dis
|
2005
|
1.13
|
34
|
Pediatric inflammatory bowel disease: what children can teach adults.
|
Inflamm Bowel Dis
|
2005
|
1.11
|
35
|
Laboratory values for children with newly diagnosed inflammatory bowel disease.
|
Pediatrics
|
2007
|
1.10
|
36
|
Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2011
|
1.03
|
37
|
Current therapy of inflammatory bowel disease in children.
|
Paediatr Drugs
|
2006
|
1.02
|
38
|
Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings.
|
Am J Surg Pathol
|
2004
|
1.00
|
39
|
Factors that determine risk for surgery in pediatric patients with Crohn's disease.
|
Clin Gastroenterol Hepatol
|
2010
|
1.00
|
40
|
Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts.
|
J Pediatr
|
2007
|
0.99
|
41
|
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
|
Inflamm Bowel Dis
|
2006
|
0.99
|
42
|
Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2006
|
0.98
|
43
|
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease.
|
Inflamm Bowel Dis
|
2009
|
0.97
|
44
|
Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis.
|
Inflamm Bowel Dis
|
2010
|
0.94
|
45
|
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease.
|
PLoS One
|
2013
|
0.93
|
46
|
Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn's disease.
|
J Magn Reson Imaging
|
2012
|
0.93
|
47
|
Nutritional concerns in pediatric inflammatory bowel disease patients.
|
Mol Nutr Food Res
|
2008
|
0.91
|
48
|
O-017 YI Inflammatory Versus Non-inflammatory Predictors of Specific Depressive Symptoms in a Large Pediatric Cohort with IBD.
|
Inflamm Bowel Dis
|
2016
|
0.91
|
49
|
Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease.
|
Am J Surg Pathol
|
2015
|
0.90
|
50
|
Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease.
|
J Pediatr Gastroenterol Nutr
|
2013
|
0.89
|
51
|
Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers.
|
Inflamm Bowel Dis
|
2006
|
0.88
|
52
|
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
|
Am J Gastroenterol
|
2011
|
0.87
|
53
|
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.
|
J Pediatr Gastroenterol Nutr
|
2010
|
0.86
|
54
|
Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2013
|
0.86
|
55
|
Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy.
|
J Pediatr Gastroenterol Nutr
|
2010
|
0.86
|
56
|
Immunizations in patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2009
|
0.86
|
57
|
Innate and adaptive immune connections in inflammatory bowel diseases.
|
Curr Opin Gastroenterol
|
2010
|
0.86
|
58
|
Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort.
|
Inflamm Bowel Dis
|
2011
|
0.86
|
59
|
Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis.
|
J Pediatr Surg
|
2013
|
0.86
|
60
|
Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease.
|
J Int Neuropsychol Soc
|
2012
|
0.85
|
61
|
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.
|
J Pediatr Gastroenterol Nutr
|
2013
|
0.85
|
62
|
Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms.
|
J Clin Psychol Med Settings
|
2012
|
0.84
|
63
|
Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor.
|
Compr Psychiatry
|
2012
|
0.84
|
64
|
The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease.
|
Inflamm Bowel Dis
|
2014
|
0.83
|
65
|
Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery.
|
J Pediatr Surg
|
2007
|
0.83
|
66
|
Restorative proctocolectomy and ileal pouch-anal anastomosis in children.
|
Dis Colon Rectum
|
2009
|
0.82
|
67
|
Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores.
|
J Pediatr Gastroenterol Nutr
|
2011
|
0.82
|
68
|
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.
|
BMC Gastroenterol
|
2014
|
0.82
|
69
|
Challenges and progress in pediatric inflammatory bowel disease.
|
Curr Opin Gastroenterol
|
2007
|
0.81
|
70
|
Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.
|
Inflamm Bowel Dis
|
2014
|
0.80
|
71
|
Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease.
|
Inflamm Bowel Dis
|
2015
|
0.80
|
72
|
Pediatric ulcerative colitis: a practical guide to management.
|
Paediatr Drugs
|
2014
|
0.78
|
73
|
The overlap of functional abdominal pain in pediatric Crohn's disease.
|
Inflamm Bowel Dis
|
2013
|
0.78
|
74
|
Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders.
|
Inflamm Bowel Dis
|
2015
|
0.78
|
75
|
Isolated neonatal swallowing dysfunction: a case series and review of the literature.
|
Dig Dis Sci
|
2003
|
0.77
|
76
|
Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease.
|
J Pediatr Gastroenterol Nutr
|
2002
|
0.77
|
77
|
Functional significance of single nucleotide polymorphisms in the lactase gene in diverse US patients and evidence for a novel lactase persistence allele at -13909 in those of European ancestry.
|
J Pediatr Gastroenterol Nutr
|
2015
|
0.76
|
78
|
Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.76
|
79
|
Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation.
|
J Pediatr Gastroenterol Nutr
|
2002
|
0.76
|
80
|
Probiotic for new onset ulcerative colitis in children: baby's got bac(teria).
|
Inflamm Bowel Dis
|
2010
|
0.75
|
81
|
NASPGHAN single-topic symposium: discovering the future of pediatric IBD care.
|
J Pediatr Gastroenterol Nutr
|
2014
|
0.75
|
82
|
Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD.
|
Inflamm Bowel Dis
|
2015
|
0.75
|
83
|
"Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis.
|
J Clin Gastroenterol
|
2011
|
0.75
|
84
|
Authors' response.
|
J Pediatr Gastroenterol Nutr
|
2014
|
0.75
|
85
|
Blocking lymphocyte adhesion: new treatment for sticky cases of Crohn disease?
|
J Pediatr Gastroenterol Nutr
|
2003
|
0.75
|
86
|
Healthcare burden of inflammatory bowel disease in the United States: more than pain and diarrhea.
|
Inflamm Bowel Dis
|
2009
|
0.75
|
87
|
Workshop report: prevention of postoperative recurrence in Crohn's disease.
|
J Pediatr Gastroenterol Nutr
|
2005
|
0.75
|
88
|
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
89
|
Outcomes from Pediatric Gastroenterology Maintenance of Certification Using Web-based Modules.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.75
|
90
|
NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Inhibitors.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.75
|
91
|
Budesonide use in pediatric Crohn disease.
|
J Pediatr Gastroenterol Nutr
|
2012
|
0.75
|
92
|
Postoperative Complications in Children With Crohn Disease Treated With Infliximab.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.75
|
93
|
O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
94
|
Normal homocysteine levels in a population of children with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2005
|
0.75
|
95
|
Medical therapy for refractory pediatric Crohn's disease.
|
Clin Gastroenterol Hepatol
|
2006
|
0.75
|
96
|
Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.
|
Expert Rev Clin Immunol
|
2013
|
0.75
|